Skip to main content
The Globe and Mail
Support Quality Journalism
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); }
Coronavirus information
Coronavirus information
The Zero Canada Project provides resources to help you make the most of staying home.
Visit the hub

What would seem like a sure win for elite investors – early bets on companies racing to make face masks, hand sanitizer and other coronavirus-related protective products – turned out to be a relatively unpopular strategy and one with surprisingly mixed results.

Few hedge funds increased their holdings over the first quarter in companies associated with personal protective equipment, or PPE, such as 3M Co., Kimberly-Clark Corp. and Honeywell International Inc., according to a Reuters review of regulatory filings compiled by research firm Symmetric.io showing stock positions as of March 31.

Hedge funds, on a net basis, sold off more than US$760-million in those three stocks over the first quarter, according to Symmetric.io data, bringing the number of funds that own them down to 225 from 230.

Story continues below advertisement

Ironically, firms that seized on the opportunity early, including Maverick Capital, Point72 Asset Management and D.E. Shaw Group, have likely faced paper losses given share price declines so far this year, assuming they still hold those stocks.

Playing the pandemic, investors said, was difficult amid roller-coaster trading fuelled by fears of the virus’ spread, surging unemployment rates, tumbling oil prices and government stimulus spending. By the end of March, the S&P 500 stock index had ended its 11-year bull market run and was down about 20 per cent for the year.

Adding to the complexity, the large companies now closely associated with protective equipment faced separate challenges.

St. Paul, Minn.-based 3M, for example, became a household mask name as people around the country raced to hardware stores and online to buy the company’s N95 products. But the company’s stock price is down 15.4 per cent this year as mask sales make up only a small portion of revenue, broadly hit as products for the manufacturing sector lagged as factories such as automakers were shut down.

Hedge fund firms Alyeska Investment Group, Laurion Capital Management, Point72 and Balyasny Asset Management all put on new positions in 3M during the first quarter, filings show; Millennium Management added to its sizable holdings.

Representatives for the firms declined to comment on the investments or did not respond to requests.

Honeywell, which makes electronics and materials for the aerospace, building and other industries, also ramped up its mask-making business as the virus spread.

Story continues below advertisement

Maverick, already a top holder, added to its stake in the first quarter and Arrowstreet Capital, put on a new position, filings show. Still, Honeywell’s stock price is off 24.3 per cent, more than the S&P 500’s roughly 8-per-cent loss this year.

Hedge fund bets on smaller PPE-focused companies produced better results.

Balyasny and Arrowstreet were among the hedge funds to initiate investments over the first quarter in protective clothing maker Lakeland Industries, valued at US$108-million. Lakeland’s stock price is up 26 per cent this year.

Tudor Investment Corp, Millennium and Arrowstreet all made new investments in MSA Safety during the first quarter, filings show. Stock of MSA, which makes protective face gear among other things, has gained 12 per cent in the past four weeks, but remains down 4 per cent for the year.

And Tiburon Opportunity Fund LP, a small hedge fund that usually focuses on financial stocks, held and slightly added to its position in Edison Nation Inc., which recently scored a large sanitizer and mask contract. The small company’s stock price rocketed higher to now trade with a 22-per-cent gain for the year.

Tiburon boss Peter Bortel told Reuters that his fund is down about 16 per cent for the year but that PPE-related bets have helped mitigate those losses.

Story continues below advertisement

“There was clearly a great business opportunity,” Mr. Bortel said.

Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter. Sign up today.

Report an error
Tickers mentioned in this story
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies